The S&P BSE Healthcare Index rose 539.12 factors, or 2.13%, to 25867.27 at 09:50 IST, with Healthcare shares buying and selling in inexperienced.
Among the many elements of S&P BSE Healthcare Index are Astrazeneca Pharma India Ltd (up 6.69%), Poly Medicure Ltd (5.43%), Panacea Biotec Ltd (4.99%), Thyrocare Applied sciences Ltd (4.97%), SMS Prescribed drugs Ltd. (As much as 4.91%), had been the highest gainers. Different beneficiaries had been Pfizer Ltd (up 4.56%), Morepen Laboratories Ltd (4.55%), Cipla Ltd (4.44%), Kopran Ltd (4.1%) and Shalby Ltd (3.88%).
However, Kovai Medical Heart & Hospital Ltd (5.51% down), Sastasunder Ventures Ltd (3.61%) and TTK Healthcare Ltd (2.53% down) went down.
At 09:50 IST, the S&P BSE Sensex fell by 807.31 or 1.37% to 57987.78.
The Nifty 50 Index was down 233.6 factors or 1.33% at 17302.65.
The S&P BSE Small-Cap Index was down 169.41 factors, or 0.59%, at 28653.34.
The S&P BSE 150 Midcap Index was down 106.08 factors, or 1.19%, at 8818.18.
On the BSE, 1127 shares had been buying and selling in inexperienced, 1645 had been buying and selling in purple and 102 had been unchanged.
Run by Capital Market – Stay Information
(This story has not been edited by Enterprise Commonplace employees and has been auto-generated from the Syndicate feed.)
Enterprise Commonplace has all the time strived to supply up-to-date data and commentary on developments which are of curiosity to you and have broad political and financial implications for the nation and the world. Your encouragement and fixed suggestions on learn how to make our supply higher strengthens our dedication to those beliefs. Even in these troublesome instances arising from Covid-19, we’re dedicated to conserving you knowledgeable and up-to-date with credible information, authoritative opinions and sharp feedback on compatibility points.
Nonetheless, our request is.
As we struggle the financial affect of the epidemic, we want extra of your help in order that we are able to proceed to offer you extra high quality content material. Our subscription mannequin has obtained encouraging suggestions from a lot of you who’ve subscribed to our on-line content material. Extra subscriptions to our on-line content material can solely assist us obtain our targets of providing you higher and extra related content material. We consider in free, honest and credible journalism. Your help via extra subscriptions might help us research journalism for which we’re dedicated.
Assist high quality journalism and Subscribe to Enterprise Commonplace.